MXPA04003755A - Endoprotesis vasculares. - Google Patents

Endoprotesis vasculares.

Info

Publication number
MXPA04003755A
MXPA04003755A MXPA04003755A MXPA04003755A MXPA04003755A MX PA04003755 A MXPA04003755 A MX PA04003755A MX PA04003755 A MXPA04003755 A MX PA04003755A MX PA04003755 A MXPA04003755 A MX PA04003755A MX PA04003755 A MXPA04003755 A MX PA04003755A
Authority
MX
Mexico
Prior art keywords
stents
formula
making
methods
well
Prior art date
Application number
MXPA04003755A
Other languages
English (en)
Spanish (es)
Inventor
Meulien Didier
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Publication of MXPA04003755A publication Critical patent/MXPA04003755A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/04Use of organic materials, e.g. acetylsalicylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Surgery (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials Engineering (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MXPA04003755A 2001-10-24 2002-10-11 Endoprotesis vasculares. MXPA04003755A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10152460A DE10152460A1 (de) 2001-10-24 2001-10-24 Stents
PCT/EP2002/011402 WO2003035133A1 (de) 2001-10-24 2002-10-11 Stents

Publications (1)

Publication Number Publication Date
MXPA04003755A true MXPA04003755A (es) 2004-07-23

Family

ID=7703557

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04003755A MXPA04003755A (es) 2001-10-24 2002-10-11 Endoprotesis vasculares.

Country Status (22)

Country Link
US (1) US20050064006A1 (enExample)
EP (1) EP1439869A1 (enExample)
JP (1) JP2005506151A (enExample)
KR (1) KR20040074977A (enExample)
CN (1) CN1575189A (enExample)
AU (1) AU2002340549B2 (enExample)
BR (1) BR0213481A (enExample)
CA (1) CA2464290A1 (enExample)
DE (1) DE10152460A1 (enExample)
EC (1) ECSP045075A (enExample)
EE (1) EE200400080A (enExample)
HR (1) HRP20040456A2 (enExample)
HU (1) HUP0401760A3 (enExample)
IL (1) IL161445A0 (enExample)
MA (1) MA26341A1 (enExample)
MX (1) MXPA04003755A (enExample)
NO (1) NO20041984L (enExample)
NZ (1) NZ532443A (enExample)
PL (1) PL367968A1 (enExample)
RU (1) RU2004115757A (enExample)
WO (1) WO2003035133A1 (enExample)
ZA (1) ZA200402989B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
DE10129725A1 (de) 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
DE10300111A1 (de) * 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
DE10355461A1 (de) * 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
EP1685841A1 (en) * 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prevention and treatment of thromboembolic disorders
DE102005045518A1 (de) * 2005-09-23 2007-03-29 Bayer Healthcare Ag 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
DE102005047558A1 (de) * 2005-10-04 2008-02-07 Bayer Healthcare Ag Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen
PT1934208E (pt) 2005-10-04 2011-06-01 Bayer Schering Pharma Ag Nova forma polimorfa de 5-cloro-n-({(5s)-2-oxo-3-[4-(3- oxo-4-morfolinil)-fenil]-1,3-oxazolidin-5-il}-metil)-2- tiofenocarboxamida
DE102005047561A1 (de) 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
US20070097252A1 (en) * 2005-10-31 2007-05-03 Silverstein D A Imaging methods, cameras, projectors, and articles of manufacture
DE102006034916A1 (de) * 2006-07-28 2008-01-31 Bayer Healthcare Ag Beschichtung künstlicher Oberflächen von medizinischen Hilfsmitteln und Geräten sowie Reinigung und/oder Vorbehandlung von Kathetern und anderen medizinischen Hilfsmitteln und Geräten
DE102006051625A1 (de) * 2006-11-02 2008-05-08 Bayer Materialscience Ag Kombinationstherapie substituierter Oxazolidinone
EP2220079A2 (en) * 2007-11-15 2010-08-25 Boehringer Ingelheim International GmbH Substituted amides, manufacturing and use thereof as medicaments
JP2023527328A (ja) * 2020-05-26 2023-06-28 エリクシアー メディカル コーポレイション 抗凝固化合物ならびにその使用のための方法およびデバイス
US11654036B2 (en) 2020-05-26 2023-05-23 Elixir Medical Corporation Anticoagulant compounds and methods and devices for their use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2134870T3 (es) * 1993-05-01 1999-10-16 Merck Patent Gmbh Antagonistas del receptor de adhesion.
US6133256A (en) * 1997-04-14 2000-10-17 Cor Therapeutics Inc Selective factor Xa inhibitors
US6273913B1 (en) * 1997-04-18 2001-08-14 Cordis Corporation Modified stent useful for delivery of drugs along stent strut
US20010029351A1 (en) * 1998-04-16 2001-10-11 Robert Falotico Drug combinations and delivery devices for the prevention and treatment of vascular disease
DE19962924A1 (de) * 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
DE10105989A1 (de) * 2001-02-09 2002-08-14 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung

Also Published As

Publication number Publication date
EP1439869A1 (de) 2004-07-28
NZ532443A (en) 2005-11-25
KR20040074977A (ko) 2004-08-26
NO20041984L (no) 2004-05-13
EE200400080A (et) 2004-08-16
IL161445A0 (en) 2004-09-27
DE10152460A1 (de) 2003-05-08
BR0213481A (pt) 2004-11-03
US20050064006A1 (en) 2005-03-24
RU2004115757A (ru) 2005-04-10
ZA200402989B (en) 2005-04-20
JP2005506151A (ja) 2005-03-03
HUP0401760A3 (en) 2008-04-28
ECSP045075A (es) 2004-05-28
WO2003035133A1 (de) 2003-05-01
AU2002340549B2 (en) 2007-11-29
PL367968A1 (en) 2005-03-07
CN1575189A (zh) 2005-02-02
MA26341A1 (fr) 2004-10-01
HRP20040456A2 (en) 2005-06-30
HUP0401760A2 (hu) 2004-12-28
CA2464290A1 (en) 2003-05-01

Similar Documents

Publication Publication Date Title
PL369530A1 (en) Chemical compounds
MXPA04003886A (es) Tiofen- y tiazolsulfonamidas como agentes antineoplasticos.
MXPA03011197A (es) Benzoilsufonamidas y sulfonilbenzamidinas que se usan como agentes antitumorales.
GB0124627D0 (en) Novel compounds
EP1432714A4 (en) CHEMICAL COMPOUNDS
DE60112974D1 (en) Carbolinderivate
AU2003228770A8 (en) Substituted pyrazolopyrimidines
DE602004021472D1 (en) Pyrimiidinverbindungen
AU2002239344A1 (en) Pyrazolopyridines
JO2654B1 (en) Multiple aryl caroxa amides are useful as lipid - lowering agents
DE60112330D1 (en) Pyrazolopyridinderivate
IL163777A0 (en) Kinase inhibitors
MXPA04003755A (es) Endoprotesis vasculares.
ZA200404752B (en) 6-aminomorphinane derivatives method for the production and use thereof
DE60216233D1 (en) Carbolinderivate
MXPA03002911A (es) Compuestos quimicos.
GB0011358D0 (en) Novel use
DE69938192D1 (en) Imidazonaphthyridine
AU2003290592A1 (en) Antitumor benzoylsulfonamides
SI1377574T1 (enExample)
DE60201074D1 (en) Pyrazolopyridinderivate
AU2002357740A1 (en) Pyrazolo-pyridine derivatives as antiherpes agents
HUP0402341A3 (en) Compositions containing thiazol-2-ylamines for the treatment of cancer
MXPA06003345A (es) Derivados de aminopiridina como inhibidores de la no-sintasa inducible.
MXPA03008946A (es) Metodos para sintetizar compuestos que contienen fenol.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal